You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/12965
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBolon, Brad-
dc.contributor.authorBarale-Thomas, Erio-
dc.contributor.authorBradley, Alys-
dc.contributor.authorEttlin, Robert A.-
dc.contributor.authorFranchi, Carla Adriene da Silva-
dc.contributor.authorGeorge, Catherine-
dc.contributor.authorGiusti, Anna Maria-
dc.contributor.authorHall, Robert-
dc.contributor.authorJacobsen, Matthew-
dc.contributor.authorKonishi, Yoichi-
dc.contributor.authorLedieu, David-
dc.contributor.authorMorton, Daniel-
dc.contributor.authorPark, Jae-Hak-
dc.contributor.authorScudamore, Cheryl L.-
dc.contributor.authorTsuda, Hiroyuki-
dc.contributor.authorVijayasarathi, S. K.-
dc.contributor.authorWijnands, Marcel V. W.-
dc.date.accessioned2014-05-20T13:37:28Z-
dc.date.accessioned2016-10-25T16:54:08Z-
dc.date.available2014-05-20T13:37:28Z-
dc.date.available2016-10-25T16:54:08Z-
dc.date.issued2010-09-01-
dc.identifierhttp://dx.doi.org/10.1293/tox.23.171-
dc.identifier.citationJournal of Toxicologic Pathology. Tokyo: Japanese Soc Toxicologic Pathology, v. 23, n. 3, p. 171-181, 2010.-
dc.identifier.issn0914-9198-
dc.identifier.urihttp://hdl.handle.net/11449/12965-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/12965-
dc.description.abstractThe International Federation of Societies of Toxicologic Pathologists (IFSTP) proposes a common global framework for training future toxicologic pathologists who will support regulatory-type nonclinical toxicology studies. Trainees optimally should undertake a scientific curriculum of at least 5 years at an accredited institution leading to a clinical degree (veterinary medicine or medicine). Trainees should then obtain 4 or more years of intensive pathology practice during a residency and/or on-the-job "apprenticeship," at least 2 years of which must be focused on regulatory-type toxicologic pathology topics. Possession of a recognized pathology qualification (i.e., certification) is highly recommended. A non-clinical pathway (e.g., a graduate degree in medical biology or pathology) may be possible if medically trained pathologists are scarce, but this option is not optimal. Regular, lifelong continuing education (peer review of nonclinical studies, professional meetings, reading, short courses) will be necessary to maintain and enhance one's understanding of current toxicologic pathology knowledge, skills, and tools. This framework should provide a rigorous yet flexible way to reliably train future toxicologic pathologists to generate, interpret, integrate, and communicate data in regulatory-type, nonclinical toxicology studies. (J Toxicol Pathol 2010; 23: 171-181)en
dc.format.extent171-181-
dc.language.isoeng-
dc.publisherJapanese Soc Toxicologic Pathology-
dc.sourceWeb of Science-
dc.subjecttoxicologic pathologistsen
dc.subjectproposed curriculumen
dc.subjecttraining standardsen
dc.subjectregulatory-type non-clinical safety studiesen
dc.titleInternational Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studiesen
dc.typeoutro-
dc.contributor.institutionGEMpath Inc-
dc.contributor.institutionJohnson & Johnson PRD-
dc.contributor.institutionPrecclin Serv Europe-
dc.contributor.institutionEttlin Consulting AG-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionIpsen Innovat-
dc.contributor.institutionAccelera Srl-
dc.contributor.institutionCovance Labs-
dc.contributor.institutionAstraZeneca-
dc.contributor.institutionYamamoto Green Village II 303-
dc.contributor.institutionNovartis Inst BioMed Res-
dc.contributor.institutionPfizer Inc-
dc.contributor.institutionSeoul Natl Univ-
dc.contributor.institutionRoyal Vet Coll-
dc.contributor.institutionNagoya City Univ-
dc.contributor.institutionAdvinus Therapeut Pvt Ltd-
dc.contributor.institutionMerck Sharp & Dohme Ltd-
dc.description.affiliationGEMpath Inc, Longmont, CO 80503 USA-
dc.description.affiliationJohnson & Johnson PRD, Pathol, B-2340 Beerse, Belgium-
dc.description.affiliationPrecclin Serv Europe, Edinburgh EH33 2NE, Midlothian, Scotland-
dc.description.affiliationEttlin Consulting AG, CH-4142 Munchenstein, Switzerland-
dc.description.affiliationUNESP, Fac Med, Dept Patol, BR-18618000 Botucatu, SP, Brazil-
dc.description.affiliationIpsen Innovat, Toxicol, F-91940 Les Ulis, France-
dc.description.affiliationAccelera Srl, Pathol, I-20014 Milan, Italy-
dc.description.affiliationCovance Labs, Madison, WI 53704 USA-
dc.description.affiliationAstraZeneca, Safety Assessment, Macclesfield SK10 4TG, Cheshire, England-
dc.description.affiliationYamamoto Green Village II 303, Kita Ku, Osaka 5918023, Japan-
dc.description.affiliationNovartis Inst BioMed Res, WKL 136 2 94, CH-4001 Basel, Switzerland-
dc.description.affiliationPfizer Inc, Groton, CT 06340 USA-
dc.description.affiliationSeoul Natl Univ, Coll Vet Med, Lab Anim Med, Seoul, South Korea-
dc.description.affiliationRoyal Vet Coll, Dept Pathol & Infect Dis, Hatfield AL9 7TA, Herts, England-
dc.description.affiliationNagoya City Univ, Nanotoxicol Project, Mizuho Ku, Nagoya, Aichi 4678603, Japan-
dc.description.affiliationAdvinus Therapeut Pvt Ltd, Dept Safety Assessment, Bangalore 560058, Karnataka, India-
dc.description.affiliationMerck Sharp & Dohme Ltd, NL-5340 BH Oss, Netherlands-
dc.description.affiliationUnespUNESP, Fac Med, Dept Patol, BR-18618000 Botucatu, SP, Brazil-
dc.identifier.doi10.1293/tox.23.171-
dc.identifier.wosWOS:000282660200010-
dc.rights.accessRightsAcesso aberto-
dc.relation.ispartofJournal of Toxicologic Pathology-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.